Sep 2026· Current protein and peptide science· 0 citations
Medicine
TL;DR
This review explores how computational design, artificial intelligence, and peptidomimetics can generate next-generation AMPs with enhanced stability and reduced toxicity, framing their role in future antimicrobial strategies.
Abstract
The global antimicrobial resistance (AMR) crisis, projected to cause 10 million deaths annually by 2050, necessitates innovative therapeutic strategies beyond traditional antibiotics. Antimicrobial peptides (AMPs), fundamental components of innate immunity, have emerged as compelling candidates owing to their broad-spectrum activity and mechanism of action, which challenges conventional resistance development. This review critically synthesizes the latest advances in the field, where the transition from natural discovery to rational engineering is of paramount importance. This review explores how computational design, artificial intelligence, and peptidomimetics can generate next-generation AMPs with enhanced stability and reduced toxicity. Furthermore, we dissected their multifaceted mechanisms, which extend beyond membrane disruption to include immunomodulation and intracellular targeting. However, the clinical pipeline reveals significant hurdles, with recent late-stage failures of candidates such as murepavadin and surotomycin, underscoring persistent challenges in systemic toxicity and pharmacokinetics. Looking ahead, we assess promising strategies to overcome these barriers, including AMP-antibiotic synergies and targeted delivery systems. This review aims to provide a realistic and forward-looking analysis of the design principles, mechanistic complexity, and translational potential of AMPs, framing their role in future antimicrobial strategies.
Antimicrobial resistance (AMR) is a major global health threat that erodes the effectiveness of antibiotics and increases morbidity, mortality, and healthcare costs. Updated forecasts project that bacterial AMR could directly cause approximately 39 million deaths between 2025 and 2050, with annual deaths rising from 1....
P. Ashinze, Oluwadamilare Olatunbosun, Aditya Gaur et al.· Acta Microbiologica Hellenic...· 0 citations
This review synthesizes recent advances in AMP research, focusing on their structural diversity, mechanistic interactions with microbial membranes, and immunomodulatory roles in shaping host-microbe dynamics, and establishes a framework for overcoming current limitations.
Wasim Ullah Khan, Zhu-Yu Hua, Xu Xia et al.· Frontiers in Microbiology· 0 citations
Antimicrobial peptides (AMPs) have been extensively investigated as alternatives to conventional antibiotics to combat multidrug-resistant bacteria. This narrow antibiotic-replacement framework underestimates the biological and translational potential of AMPs. The present review reframes them as disease-context-depende...
Min-Ho Lee· Journal of Microbiology and...· 0 citations
The growing occurrence of antimicrobial resistance represents a major challenge to global healthcare and necessitates the development of novel therapeutic agents capable of overcoming multidrug-resistant (MDR) pathogens. Gramicidin S (GS), a cyclic decapeptide antibiotic has attracted renewed interest as a promising te...
T. S. Shkuratova, D. V. Andreeva, A. Tikhomirov et al.· Future Medicinal Chemistry· 0 citations
Recent advances in nanotechnology-based strategies for combating AMR are summarized, highlighting the mechanisms of action, therapeutic applications, current research progress, and future translational prospects.
P. Swami, Priya D. Chouragade· Journal of Drug Delivery and...· 0 citations
It is argued that the realistic near-term contribution of animal-derived AMPs lies in combination therapy with existing antibiotics and in topical or localised indications with direct clinical evidence, while their use as stand-alone systemic agents remains a preclinical and early-clinical prospect rather than an estab...
Mallu Mallikarjuna, Narasimha Golla· Probiotics and Antimicrobial...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.